Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427)

NCT00724854 · clinicaltrials.gov ↗

COMPLETED

Status

1146

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic
Hepatitis C

Interventions

BIOLOGICAL: PegIntron (peginterferon alfa-2b; SCH 54031)
DRUG: Rebetol (ribavirin; SCH 18908)

Sponsor

Merck Sharp & Dohme LLC